Importance Epidemiologic studies have shown that antidepressants may increase the risk of
angle-closure glaucoma. We examined the risk of angle-closure glaucoma with bupropion …

Objective Tumor Necrosis Factor (TNF) mediates retinal ganglion cell death in glaucoma.
Anti-TNF drugs are neuroprotective in an animal model of glaucoma. It is unclear whether …

Acute angle-closure glaucoma (AACG) is an ocular emergency that may be precipitated by
certain types of medications. Antidepressant drugs can affect a number of neurotransmitters …

Purpose To investigate the relationship between self-reported bupropion use and self-
reported glaucoma in a nationally representative sample of the US population. Methods This …

Purpose: To present a unique case of a 33-year-old woman using paroxetine who presented
with acute unilateral visual loss due to chronic angle-closure glaucoma. Methods: Case …

With increasing longevity, patients are developing more and more chronic diseases that
require treatment with medications. Yet, it is not fully understood the extent by which these …

We sought to refine understanding about associations identified in prior studies between
angiotensin‐II receptor blockers, metformin, selective serotonin reuptake inhibitors, fibric …

METHODS A systematic review and meta-analysis were conducted by searching the
electronic databases including PubMed, EMBASE, and Web of Science from their inception …

ary acute angle-closure glaucoma associated with topiramate (Topamax; Ortho-McNeil
Pharmaceutical, Inc, Raritan, NJ) and submitted to the Food and Drug Administration's …

PURPOSE: To investigate the effect of topical β-blockers on the prevalence of depression
among glaucoma patients. DESIGN: Retrospective observational population-based cohort …